<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="id">6296</item><item key="factors"><item><item key="GSM635583"><item key="TRREATMENT">3 daily administrations of IL-25.</item><item key="TIME">0 days in culture</item></item></item><item><item key="GSM635583"><item key="TRREATMENT">3 daily administrations of IL-25.</item><item key="TIME">0 days in culture</item></item></item><item><item key="GSM635585"><item key="TRREATMENT">3 daily administrations of IL-25 and cultured with IL-33 and IL-7 (both at 10 nanograms /ml) for 9 days.</item><item key="TIME">9 days in culture</item></item></item><item><item key="GSM635585"><item key="TRREATMENT">3 daily administrations of IL-25 and cultured with IL-33 and IL-7 (both at 10 nanograms /ml) for 9 days.</item><item key="TIME">9 days in culture</item></item></item><item><item key="GSM635585"><item key="TRREATMENT">3 daily administrations of IL-25 and cultured with IL-33 and IL-7 (both at 10 nanograms /ml) for 9 days.</item><item key="TIME">9 days in culture</item></item></item></item><item key="pop_total">0</item><item key="platform">6</item><item key="summary_wrapped">Nuocytes are a recently described cell that responds to both IL-25 and IL-33 and produce high levels of IL-13 and IL-5 Mice were...</item><item key="pubmed_id">20200518</item><item key="geo_gse_id">E-GEOD-25890</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">2</item><item key="sample_count">5</item><item key="tags"><item>cell</item><item>spleen</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_id_plat">E-GEOD-25890_A-AFFY-45</item><item key="slug">expression-data-from-mouse-nuocytes</item><item key="geo_gds_id"/><item key="name">Expression data from mouse Nuocytes</item><item key="created">Nov.11, 2014</item><item key="summary">Nuocytes are a recently described cell that responds to both IL-25 and IL-33 and produce high levels of IL-13 and IL-5 Mice were administered with 3 daily doses of IL-25 (400 ng/dose).  Nuocytes were purified by flow cytometry. Spleen cells prepared from IL-25-treated mice were depleted of lineage+ cells before cell sorting by incubation with biotin-conjugated anti-CD3, anti-CD19, anti-CD11b and anti-Fc&#949;RI antibodies before removal of antibody-bound cells by magnetic separation using Dynabeads (Invitrogen). Lineage-depleted cells were stained with PE-conjugated antibodies against CD4, CD8, B220, TER-119 and CD11b, a FITC-conjugated antibody against CD45, and an APC-conjugated antibody against ICOS. PE&#8722;, FITC+, APC+ cells were collected using a Mo-flo cell sorter, and purity was checked by staining with lineage antibodies and antibodies against IL-17BR and T1/ST2.  Following purification nuocytes were prepared directly for microarray gene expression analysis or cultured with IL-33 and IL-7 (both at 10 nanograms/ml) for 9 days before being prepared for microarray gene expression analysis.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-25890</item><item key="species">mouse</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-25890/samples/</item></data></biogps>
